# Aldeyra Therapeutics, Inc. – FDA Inspection, Apr 28, 2023

Source: https://www.keypedia.com/records/fda_inspections/aldeyra-therapeutics-inc/b05797b9-b4be-468a-9213-c72e5207bfdf
Source feed: FDA_Inspections

> FDA inspection 1204017 of Aldeyra Therapeutics, Inc., April 28, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204017
- Company Name: Aldeyra Therapeutics, Inc.
- Inspection Date: 2023-04-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/aldeyra-therapeutics-inc/1a871130-ca82-4441-a7a4-7d7c28561ffa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c